NCT02950259 2025-12-03Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)Providence Health & ServicesPhase 1 Completed16 enrolled 10 charts
NCT00001337 2025-06-22Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's LymphomaNational Institutes of Health Clinical Center (CC)Phase 2 Completed348 enrolled 15 charts